Hostname: page-component-5db58dd55d-l8wb7 Total loading time: 0 Render date: 2026-06-01T16:18:31.429Z Has data issue: false hasContentIssue false
  • English
  • Français

Triacylglycerol and coronary heart disease

Published online by Cambridge University Press:  28 February 2007

Melissa A. Austin
Melissa A. Austin
Affiliation:
Department of Epidemiology, School of Public Health and Community Medicine, Box 357236, University of Washington, Seattle, Washington, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Research Article
Information
Proceedings of the Nutrition Society , Volume 56 , Issue 2 , July 1997 , pp. 667 - 670
Copyright
Copyright © The Nutrition Society 1997

References

REFERENCES

Assmann, G., Schulte, H. & von Eckardstein, A. (1996). Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. American Journal of Cardiology 77, 1179–1184.CrossRefGoogle ScholarPubMed
Austin, M. A. (1991). Triglycerides and coronary heart disease. Arteriosclerosis & Thrombosis 11, 2–14.CrossRefGoogle ScholarPubMed
Austin, M. A., Breslow, J. L., Hennekens, C. H., Buring, J. E., Willett, W. S. & Krauss, R. M. (1988). Low-density lipoprotein subclass patterns and risk of myocardial infarction. Journal of the American Medical Association 260, 1917–1921.Google ScholarPubMed
Austin, M.A, Hokanson, J. E. & Brunzell, J. D. (1994). Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Current Opinion in Lipidology 5, 395–403.CrossRefGoogle ScholarPubMed
Austin, M. A., King, M.-C., Vranizan, K. M. & Krauss, R. M. (1990). Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 82, 495–506.CrossRefGoogle ScholarPubMed
Austin, M. A., Mykkänen, L., Kuusisto, J., Edwards, K. L., Nelson, C., Haffner, S. M., Pyörälä, K. & Laakso, M. (1995). Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes. Circulation 92, 1770–1778.CrossRefGoogle ScholarPubMed
Burchfiel, C. M., Laws, A., Benfante, R., Goldberg, R. J., Hwang, I.-J., Chiu, D., Rodriguez, B. L., Curb, J. D. & Sharp, D. S. (1995). Combined effects of HDL cholesterol, triglyceride and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 92, 1430–1436.CrossRefGoogle ScholarPubMed
Defronzo, R. A. & Ferrannini, E. (1991). Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14, 173–194.CrossRefGoogle ScholarPubMed
Edwards, K. L., Austin, M. A., Newman, B., Mayer, E., Krauss, R. M. & Selby, J. V. (1994). Multivariate analysis of the insulin resistance syndrome in women. Arteriosclerosis & Thrombosis 14, 1940–1945.CrossRefGoogle ScholarPubMed
Edwards, K. L., Burchfiel, C. M., Sharp, D. S., Curb, J. D., Rodriguez, B. L., LaCroix, A. Z., Vitiello, M. V. & Austin, M. A. (1996). Multivariate factors of the insulin resistance syndrome (IRS) in elderly Japanese American men. Diabetes 45, Suppl. 2, 280A.Google Scholar
Ferrannini, E., Haffner, S. M., Mitchell, B. D. & Stem, M. P. (1991). Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416–422.Google ScholarPubMed
Gardner, C. D., Fortmann, S. P. & Krauss, R. M. (1996). Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. Journal of the American Medical Association 276, 875–881.CrossRefGoogle ScholarPubMed
Griffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J. & Shepherd, J. (1994). Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106, 241–253.CrossRefGoogle ScholarPubMed
Hokanson, J. E. & Austin, M. A. (1996). Plasma triglyceride level is an independent risk factor for cardiovascular disease: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 3, 213–219.CrossRefGoogle ScholarPubMed
Levine, G. N., Keaney, J. F. & Vita, J. A. (1995). Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. New England Journal of Medicine 332, 512–521.CrossRefGoogle ScholarPubMed
Mahaney, M. C., Blangero, J., Comuzzie, A. G., Vandeberg, J. L., Stem, M. P. & MacCluer, J. W. (1995). Plasma HDL cholesterol, triglyceride and adiposity. A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Heart Study. Circulation 92, 3240–3248.CrossRefGoogle Scholar
NIH Consensus Development Panel on Triglyceride High Density Lipoprotein and Coronary Heart Disease (1993). Triglyceride, high density lipoprotein and coronary heart disease. Journal of the American Medical Association 269, 505–510.CrossRefGoogle Scholar
Reaven, G. M. (1988). Role of insulin resistance in human disease. Diabetes 37, 1595–1607.CrossRefGoogle ScholarPubMed
Reaven, G. M., Chen, I. Y.-D., Jeppesen, J., Maheux, P. & Krauss, R. M. (1993). Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. Journal of Clinical Investigation 92, 141–146.CrossRefGoogle ScholarPubMed
Scandinavian Simvastatin Survival Study Group (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383–1389.Google Scholar
Selby, J. V., Austin, M. A., Newman, B., Zhang, D., Quesenberry, C. P., Mayer, E. J. & Krauss, R. M. (1993). LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88, 381–387.CrossRefGoogle ScholarPubMed
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., MacFarlane, P. W., McKillop, J. H. & Packard, C. J. for the West of Scotland Coronary Prevention Study Group (1995). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine 333, 1301–1307.CrossRefGoogle ScholarPubMed
Sprecher, D. L., Hein, M. J. & Laskarzewski, P. M. (1994). Conjoint high triglycerides and low HDL cholesterol across generations. Analysis of proband hypertriglyceridemia and lipid/lipoprotein disorders in first-degree family members. Circulation 90, 1177–1184.CrossRefGoogle ScholarPubMed
Stampfer, M. J., Krauss, R. M., Blance, P. J., Holl, L. G., Sacks, F. M. & Hennekens, C. H. (1996). A prospective study of triglyceride level, low-density lipoprotein particle diameter and risk of myocardial infarction. Journal of the American Medical Association 276, 882–915.CrossRefGoogle ScholarPubMed